NCT03637569 The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
| NCT ID | NCT03637569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Pancreas Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-04-01 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-04-01 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, the investigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed pancreatic, bile duct or gallbladder cancer patients, undergoing therapeutic management (including surgery, chemotherapy or palliative care). * Age above 18 years old Exclusion Criteria: * Other malignant disease * Underlying intestinal disease that cause absorprtion disorder * Underlying psychiatric disorder such as eating disorder (bulimia, anorexia)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03637569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreas Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03637569 currently recruiting?
Yes, NCT03637569 is actively recruiting participants. Contact the research team at ji.chang@samsung.com for enrollment information.
Where is the NCT03637569 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT03637569 clinical trial?
NCT03637569 is sponsored by Samsung Medical Center. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.